These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 31601607)
1. Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis. Ostinelli EG; D'Agostino A; Shokraneh F; Salanti G; Furukawa TA BMJ Open; 2019 Oct; 9(10):e032726. PubMed ID: 31601607 [TBL] [Abstract][Full Text] [Related]
2. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Powney MJ; Adams CE; Jones H Cochrane Database Syst Rev; 2012 Nov; 11():CD009377. PubMed ID: 23152276 [TBL] [Abstract][Full Text] [Related]
4. De-escalation techniques for psychosis-induced aggression or agitation. Du M; Wang X; Yin S; Shu W; Hao R; Zhao S; Rao H; Yeung WL; Jayaram MB; Xia J Cochrane Database Syst Rev; 2017 Apr; 4(4):CD009922. PubMed ID: 28368091 [TBL] [Abstract][Full Text] [Related]
5. Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials. Bighelli I; Salanti G; Reitmeir C; Wallis S; Barbui C; Furukawa TA; Leucht S BMJ Open; 2018 Mar; 8(3):e019280. PubMed ID: 29540411 [TBL] [Abstract][Full Text] [Related]
6. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting. Correll CU; Yu X; Xiang Y; Kane JM; Masand P Ann Clin Psychiatry; 2017 May; 29(2):92-107. PubMed ID: 28463343 [TBL] [Abstract][Full Text] [Related]
7. Chlorpromazine for psychosis induced aggression or agitation. Ahmed U; Jones H; Adams CE Cochrane Database Syst Rev; 2010 Apr; (4):CD007445. PubMed ID: 20393959 [TBL] [Abstract][Full Text] [Related]
8. Network meta-analysis on the comparative efficacy of family interventions for psychotic disorders: a protocol. Laskowski A; Lincoln TM BMJ Open; 2021 Jan; 11(1):e039777. PubMed ID: 33472774 [TBL] [Abstract][Full Text] [Related]
9. Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials. Schneider-Thoma J; Kapfhammer A; Wang D; Bighelli I; Siafis S; Wu H; Hansen WP; Davis JM; Salanti G; Leucht S Syst Rev; 2021 Aug; 10(1):214. PubMed ID: 34340713 [TBL] [Abstract][Full Text] [Related]
10. Network meta-analysis of randomised trials of pharmacological, psychotherapeutic, exercise and collaborative care interventions for depressive symptoms in patients with coronary artery disease: hybrid systematic review of systematic reviews protocol. Doyle F; Freedland K; Carney R; de Jonge P; Dickens C; Pedersen S; Sorensen J; Dempster M Syst Rev; 2019 Mar; 8(1):71. PubMed ID: 30878039 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis. Gobbi G; Gaudreau PO; Leblanc N J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186 [TBL] [Abstract][Full Text] [Related]
12. Haloperidol plus promethazine for psychosis induced aggression. Huf G; Alexander J; Allen MH Cochrane Database Syst Rev; 2005 Jan; (1):CD005146. PubMed ID: 15654706 [TBL] [Abstract][Full Text] [Related]
13. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [TBL] [Abstract][Full Text] [Related]
14. Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence. Bighelli I; Rodolico A; Pitschel-Walz G; Hansen WP; Barbui C; Furukawa TA; Salanti G; Leucht S BMJ Open; 2020 Jan; 10(1):e035073. PubMed ID: 31959613 [TBL] [Abstract][Full Text] [Related]
15. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants. O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis. Cortese S; Adamo N; Mohr-Jensen C; Hayes AJ; Bhatti S; Carucci S; Del Giovane C; Atkinson LZ; Banaschewski T; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A; Coghill D; BMJ Open; 2017 Jan; 7(1):e013967. PubMed ID: 28073796 [TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder. San L; Estrada G; Oudovenko N; Vieta E BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis. Feber L; Peter N; Schneider-Thoma J; Siafis S; Bighelli I; Hansen WP; Prates Baldez D; Salanti G; Keefe RSE; Engel RR; Leucht S Syst Rev; 2023 Mar; 12(1):54. PubMed ID: 36959619 [TBL] [Abstract][Full Text] [Related]